79311144 - TIGEN

Information

  • Trademark
  • 79311144
  • Serial Number
    79311144
  • Filing Date
    February 04, 2021
    3 years ago
  • Transaction Date
    January 31, 2024
    9 months ago
  • Status Date
    March 28, 2022
    2 years ago
  • Published for Opposition Date
    February 15, 2022
    2 years ago
  • Location Date
    January 11, 2022
    2 years ago
  • Status Code
    774
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    AGREDA, SAMANTHA LEIGH
  • Attorney Docket Number
    EBLM068.003I
    Attorney Name
    STACEY HALPERN
    Law Office Assigned Location Code
    N50
  • Owners
Mark Drawing Code
5000
Mark Identification
TIGEN
Case File Statements
  • GS0051: Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases
  • GS0011: Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals
  • GS0441: Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists
  • GS0101: Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions
  • GS0421: Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services
Case File Event Statements
  • 12/31/2023 - 10 months ago
    40 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 12/11/2023 - 10 months ago
    39 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 11/8/2023 - 11 months ago
    38 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/8/2023 - 11 months ago
    37 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 8/2/2022 - 2 years ago
    36 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 6/5/2022 - 2 years ago
    35 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 4/10/2022 - 2 years ago
    34 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/28/2022 - 2 years ago
    33 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 3/16/2022 - 2 years ago
    32 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 3/16/2022 - 2 years ago
    31 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 3/15/2022 - 2 years ago
    30 - OPPOSITION PAPERS RECEIVED AT TTAB Type: OPPF
  • 2/15/2022 - 2 years ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/15/2022 - 2 years ago
    28 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/14/2022 - 2 years ago
    27 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/26/2022 - 2 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/26/2022 - 2 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/26/2022 - 2 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/11/2022 - 2 years ago
    23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/11/2022 - 2 years ago
    22 - ASSIGNED TO LIE Type: ALIE
  • 1/10/2022 - 2 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/10/2022 - 2 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/10/2022 - 2 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/10/2022 - 2 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/10/2022 - 2 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/7/2022 - 2 years ago
    16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/7/2022 - 2 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/7/2022 - 2 years ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 1/7/2022 - 2 years ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/7/2022 - 2 years ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/7/2022 - 2 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/4/2021 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/14/2021 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/14/2021 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/14/2021 - 3 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/13/2021 - 3 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/27/2021 - 3 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/20/2021 - 3 years ago
    4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/25/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/21/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/20/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR